An experimental blood test may be able to predict whether a woman with breast cancer will suffer a relapse months before new tumors would be detectable on scans, researchers said Wednesday.
The technology, described in the journal Science Translational Medicine, works by detecting cancer DNA that circulates in the bloodstream.
While the test is not yet available to the public, and likely will not be for years to come, researchers are hopeful that it could help refine personalized treatments for cancer and perhaps lead scientists further down the path of finding a cure one day.
"We have shown how a simple blood test has the potential to accurately predict which patients will relapse from breast cancer, much earlier than we can currently," said study author Nicholas Turner, team leader in molecular oncology at The Institute of Cancer Research, London.
"Ours in the first study to show that these blood tests could be used to predict relapse," he added.
Scientists took tumor and blood samples from 55 breast cancer patients with early-stage disease. Each of the patients had received chemotherapy and surgery to remove the cancer.
The blood test was administered following surgery and every six months afterward as a follow-up.
Of the 15 women who saw their cancer return, the test accurately predicted that relapse in 12 of them.
The test also detected cancer an average of about eight months earlier than the tumors were visibly detectable on conventional scans.
The technique uses personalized digital polymerase chain reaction (dPCR) tests to track mutations and could be applied to all subtypes of breast cancer, the study said.
Turner said there are some technical challenges to implementing the technology, "but digital PCR is relatively cost-effective and the information that it provides could make a real difference to breast cancer patients."
Breast cancer is diagnosed early in 95 percent of cases, but knowing whether or not treatment is able to remove all signs of cancer is key to preventing the tumors from returning and spreading elsewhere in the body.
"It will be some years before the test could potentially be available in hospitals, but we hope to bring this date closer by conducting much larger clinical trials starting next year," Turner said.
AFP RELAXNEWS
Thu Aug 27 2015
An experimental blood test may be able to predict whether a woman with breast cancer will suffer a relapse. - angellodeco/shutterstock.com
'Tulisan jawi tiada kaitan Jelajah Perikatan Nasional' - MUDA Kelantan
MUDA Kelantan menegaskan tulisan jawi tertera pada sepanduknya adalah logo rasmi baharu cawangan itu, dan tiada kaitan dengan program Jelajah Perikatan Nasional (PN).
Ops Lebih Muatan: JPJ keluar 126 notis saman, 13 kenderaan barangan dikenakan tindakan
Sebanyak 126 notis saman dikeluarkan JPJ Pulau Pinang terhadap pemandu kenderaan barangan menerusi Ops Khas Lebih Muatan di sekitar negeri ini.
AWANI Ringkas: Bas terbalik di Lebuh Raya Karak
Ikuti rangkuman berita utama yang menjadi tumpuan sepanjang hari di Astro AWANI menerusi AWANI Ringkas.
Lelaki mengaku rogol, cabul anak kandung
Dia didakwa melakukan perbuatan itu di sebuah rumah di Kampung Seri Rahmat, Batu Gajah pada jam 10 hingga 12 malam, Februari lalu.
Piala Uber: Pearly ambil sudut positif jika tidak ke Chengdu
Pearly Tan tidak berasa kecil hati sekiranya beliau dan pasangan M. Thinaah, tidak disenaraikan ke skuad Piala Uber 2024 di Chengdu, China.
Bubur Lambuk Ayam Belanda hidangan istimewa di Kampung Parit Sikom
Istimewa Ramadan 2024, penduduk kampung Parit Sikom, Pontian, Johor menikmati hidangan istimewa, Bubur Lambuk Ayam Belanda, yang diedarkan sebanyak 500 pek .
Penguasaan asas teknologi AI sangat penting untuk pelajar
Penguasaan terhadap asas AI adalah perlu dan penting seiring dengan penguasaan 3M (menulis, mengira dan membaca).
Pasaran saham ST1 positif, dijangka berterusan sehingga H2
Pasaran FBM KLCI mencatat prestasi baik dengan pulangan sekitar 5.7%. Imran Yassin Md Yusof, Ketua MIDF Research, menjangkakan sentimen positif akan berterusan sehingga separuh kedua tahun ini. Sektor cemerlang termasuk utiliti, hartanah, dan pembinaan.
Peningkatan IHPR beri petanda positif kepada perdagangan
Menurut Pengarah Program MBA, Putra Business School (PBS), Prof Madya Dr. Ahmed Razman Abdul Latiff, prestasi Indeks Harga Pengeluar (IHPR) Pengeluaran Tempatan Malaysia yang meningkat pada Februari 2024 menyifatkan pertumbuhan perdagangan berada di tahap yang baik.
Jangan ambil tindakan sendiri, Malaysia ada undang-undang - KPN
Ketua Polis Negara, Tan Sri Razarudin Husain memberi amaran dan peringatan keras kepada orang ramai untuk tidak mengambil tindakan sendiri.